Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Intrastent Restenosis in Ostial Lesions in the Right Coronary Artery: Predictors of an Unfavorable Location

Predictors of intrastent restenosis in the right coronary artery ostium.

The ostium of the right coronary artery (RCA) presents certain histological aspects. Atherosclerotic and fibrotic plaques in this area contain an abundance of smooth muscle, collagen, and a certain degree of calcification, along with thicker adventitia. Additionally, it has certain anatomical aspects such as poor distensibility and excessive oscillating movement.

Reestenosis intrastent en lesiones ostiales de la coronaria derecha: predictores de una localización desfavorable

During the era of balloon angioplasty, the fact that lesions in this area had a lower success rate (88%) with a high percentage of acute complications was well-known. These events were mostly due to greater recoil compared with lesions in areas other than the right coronary artery. In the era of drug-eluting stents (DES), percutaneous coronary interventions (PCI) of the RCA ostium have shown a high prevalence of intrastent restenosis (ISR), reaching as high as 7.5-12.7%.

The aim of this study presented by Yamamoto K. et al. was to investigate the mechanisms of intrastent restenosis in the RCA ostium using intravascular ultrasound (IVUS). Researchers conducted an observational, retrospective, single-center study that included patients with intrastent restenosis (defined as stenosis ≥50% or a minimal luminal area ≤4 mm by IVUS) in the RCA ostium (within 3 mm from the aorto-ostial junction).

The primary endpoint (PFP) was a composite outcome called target lesion failure (TLF), which consisted of cardiac death, target vessel revascularization, and myocardial infarction of the treated vessel.

Read also: Frequency and Causes of Mortality in Chronic Total Occlusion.

A total of 139 lesions with ostial ISR were included. The mean age was 71 years, 42.4% of patients were women, 10.1% had aortic stenosis (at least moderate), and the majority of ISR lesions were focal.

The patterns of ISR were neointimal hyperplasia (25%), neoatherosclerosis (22%), uncovered ostial lesion (6%), stent underexpansion (11%), protrusion of a calcified nodule (11%), and stent fracture or deformation (25%).

The time interval between stent implantation and ISR was shorter in patients with uncovered ostiums (0.5 [0.2-0.6] years) compared with the interval in cases of neoatherosclerosis (2.7 [1.0-5.0] years). Stents were placed in 66.9% of treated lesions, and the stenting rate in ISR due to mechanical causes (49.3%) was lower compared with that in ISR due to biological causes (82.4%).

Read also: Minimal Stent Area: New IVUS Parameter?

The incidence of the primary endpoint at one year was 11.5%. When analyzing patients with a mechanical cause and no treatment with a new stent, they experienced a higher rate of TLF (41.4%) compared with other groups (P < 0.0001).

Conclusions

Approximately half of the cases of ISR were due to mechanical causes (stent fracture, stent underexpansion, or calcified protrusion). Subsequent events were more common in those patients, especially with mechanical causes and no new stent implantation.

Therefore, when treating this area, the use of an uncovered ostium and proper stent apposition should be avoided, favoring the use of IVUS to improve positioning. In cases of fracture, consideration should be given to using more robust stents to prevent such outcomes.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.

Reference: Yamamoto K, Sato T, Salem H, et al. Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis [published online ahead of print, 2023 Jun 7]. EuroIntervention. 2023;EIJ-D-23-00107. doi:10.4244/EIJ-D-23-00107.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....